Searched for
ONCOLOGY STOCKS
156% rally in one day! Why this drugmaker stock witnessed such skyrocketing jump on Wall StreetSellas Life Sciences shares surged 156% after its experimental leukemia vaccine, galinpepimut-S (GPS), significantly extended survival in a...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%That market has seemingly shed the fear that was dominating it these past several months. However, even as a recovery takes place, it is no...
For investors with patience and ability to take moderate risk: 5 mid-cap stocks with upside potential of up to 26%For all those who have decided it is now time to turn bullish, here’s a small reminder: The past year has been a very tough one for mid-cap...
These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analystsThe probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the sam...
For investors with medium-term outlook: 5 large-cap stocks with upside potential of up to 23%, according to analystsThe headwinds hitting the market are not just easing now. Some of them are actually turning into tailwinds. That is a real change. The broa...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%The FPIs that were selling in the Indian market all these months mostly owned large-cap stocks. And as they sold them, it was that segment ...
Stock Picks of the Week: 5 stocks with consistent score improvement and upside potential of up to 35% in 1 year, according to analystsThe market weathered a whole bad patch with almost no FPI money coming in. But it cuts the other way too. When so little has been flowing i...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analystsDespite the upbeat mood in the market, remember one thing: Valuations are still not cheap. Even after everything the market has been throug...
These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
4 stocks with consistent score improvement and upside potential of up to 31% in 1 year, according to analystsAlthough the indices are in the green on Monday, the market is extremely volatile. The upmove is being attributed to some recovery in oil p...
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...
Paras Healthcare allotment likely today: Check GMP, key details and how to check statusParas Healthcare IPO allotment is expected to be finalised today after the Rs 1,450-crore issue was subscribed 2.23 times. With the GMP ind...
5 stocks with consistent score improvement and upside potential of up to 29% in 1 year, according to analystsDo not paint the whole market with one brush. Even in an extended fall like the current one, some parts of the economy still manage to hold...
Paras Healthcare IPO Day 3: Check GMP, subscription status and key detailsParas Healthcare’s Rs 1,450 crore IPO enters its final bidding day with a muted response, while a grey market premium of around 2% signals ...
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leakModerna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline era...
Stocks in news: Reliance Industries, Eternal, IREDA, Yes Bank, Trent and Hindustan ZincIndian equity benchmarks experienced a decline as profit-booking occurred amid rising crude oil prices. The Nifty 50 dropped significantly,...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up 32%, according to analystsHistory tells us that there is no way you can time the markets or predict its movement. But one thing can certainly be said: If the macro m...
Mega Jio Platforms IPO to lead Rs 31,663 crore offerings this week; 9 listings lined upIndia’s primary market is set for a busy week, led by Reliance Jio Platforms’ Rs 30,213 crore IPO and Paras Healthcare’s Rs 1,450 crore iss...